3D Systems (DDD) is expanding its footprint in the 3D Printing industry with the introduction of the EXT 800 Titan Pellet, the latest addition to its renowned EXT Titan Pellet systems portfolio.The new compact pellet extrusion system, boasting a build volume of 800 x 600 x 800 mm, combines the speed, reliability, and efficiency of the larger EXT 1070 and EXT 1270 models into a more compact and cost-effective format.Designed to meet the diverse needs of manufacturers, the EXT 800 Titan Pellet produces functi ...

Smaller footprint with lower upfront investment enables broader adoption of industrial EXT platform in existing and new marketsLeverages proven high-speed pellet extrusion technology— up to 10x faster and 10x lower costs — cheaper than available filament systems for better ROIProduction platform with refined design and open material architecture to cost-effectively address breadth of industrial applications ROCK HILL, S.C., June 18, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the latest ...

Smaller footprint with lower upfront investment enables broader adoption of industrial EXT platform in existing and new marketsLeverages proven high-speed pellet extrusion technology— up to 10x faster and 10x lower costs — cheaper than available filament systems for better ROIProduction platform with refined design and open material architecture to cost-effectively address breadth of industrial applications ROCK HILL, S.C., June 18, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the latest ...

Every forward-thinking investor is considering 3D printing stocks. The growing use of the technology in industries such as aerospace, automotive, healthcare and consumer items led to a $22 billion industry in 2023, estimated to expand 24% to $150 billion by 2032 from $28 billion in 2024.These positive predictions come from laws like Additive Manufacturing Forward (AM Forward) from the Biden administration and the use of 3D printing by local governments for a circular economy.As expected, most company leader ...

文章核心观点 - 3D Systems公司宣布与一家未具名公司签订价值高达2.5亿美元的合同,支持"间接制造过程的清洁矫正器"至2028年 [1][2] - 这对于一家营收仅4.88亿美元的公司来说是一个重大消息 [3] - 该合同将支持每天生产约100万个定制的清洁矫正器,公司的NextDent技术还可生产其他牙科设备 [3][4] 行业分析 - 行业研究显示,3D打印牙科产品市场到2032年可能达到146亿美元 [5] - 3D Systems表示,它已拥有市场上最大的牙科3D打印材料组合 [5] - 即使仅将前4年的2.5亿美元合同收入加到现有营收上,也意味着至少12%的年复合销售增长 [6] - 但能否转亏为盈仍有待观察,公司过去两年一直亏损,今年也预计无法实现盈利 [6]

3D Systems (DDD) is expanding its footprint in the digital dentistry market with its recent announcement of a comprehensive technology roadmap aimed at delivering a diverse range of solutions.The roadmap will include solutions aimed at enhancing the alignment, protection, repair and replacement of teeth, making 3D Systems a frontrunner among additive manufacturing solutions providers. The expansion comes alongside a significant multi-year purchase agreement projected to exceed a quarter-billion dollars in v ...

Company rapidly expanding market-leading solution portfolio to address all major facets of dentistry, including alignment, protection, repair, and partial/full replacement of teethAnnounces largest contract award in company history, with estimated value approaching a quarter billion dollars over five years, to support indirect manufacturing process for clear alignersCommercial launch of direct printing technology for clear aligners targeted for late 2025Dual-material printing technologies enabling expansion ...

公司概述 - 3D Systems Corporation 是一家垂直整合的3D打印公司，涉及3D打印机的开发、生产、维护和材料供应。公司通过并购策略在过去20年巩固了其在3D打印行业的地位。预计全球3D打印行业从2020年代初到2030年将以约20%的复合年增长率增长，到2030年达到约1000亿美元的市场价值[1] 生物打印机会 - 3D Systems 在生物打印领域，特别是3D器官打印方面具有重要机会。公司是少数能够大规模打印人体器官的领先企业之一，这可能显著改善全球许多人的生活质量[2][3] 财务状况 - 截至撰写时，3D Systems 的市值约为4.7亿美元，拥有约3.3亿美元的现金和3.8亿美元的债务。公司的运营现金流在过去几年中大部分为正，但净收入多数年份为负，2023财年净亏损超过3.7亿美元[6] - 公司近年来的运营现金流为负，显示核心业务面临挑战。收入多年来持平并开始下降，削弱了公司的盈利基础[7][8] 成本削减与投资 - 面对收入下降和需求疲软，3D Systems 计划削减成本以减少亏损，同时保留对新产品开发的关键投资，以支持未来的增长[9] 债务情况 - 2021年，3D Systems 发行了4.6亿美元的零息可转换债券，将于2026年11月到期。公司在2023年第四季度偿还了约30%的债务，但仍有超过3亿美元的债务需要管理[10] 器官打印市场机会 - 在美国，器官移植网络存在严重的供需不平衡，每天有超过12名美国人因等待器官而死亡。欧洲也面临类似问题。器官打印技术的发展和商业化预计将在2020年代末或2030年代初实现[12][13] - 器官打印市场预计将以近20%的复合年增长率增长，到2030年达到约70亿美元。3D Systems 预计将占据至少20%的市场份额，特别是在北美、欧洲和亚太地区[29][30] 竞争分析 - 3D Systems 在器官打印领域的直接竞争对手包括Organovo Holdings、BICO Group AB、Tissue Regenix Group plc 和 Biolife4D Corporation，但这些公司的市场资本化远小于3D Systems，且资源有限[25][26][27] 2030年股价预测 - 基于对3D Systems 在2030年的收入预测和市场机会，预计公司股票在2030年的价格可能达到每股54.62美元，较当前价格有显著增长[41][42] 风险因素 - 3D Systems 面临财务压力，包括高现金消耗和债务问题，可能导致公司在短期内财务紧张。此外，器官打印技术的商业化可能受到法律、伦理和监管障碍的影响[47][48]

3D Systems Corporation (DDD) - 3D Systems Corporation (DDD) 提供3D打印和数字制造解决方案，当前年度盈利预期在过去60天内下调了225%[1] Eagle Bancorp, Inc. (EGBN) - Eagle Bancorp, Inc. (EGBN) 是EagleBank的银行控股公司，当前年度盈利预期在过去60天内下调了8.7%[2] FinWise Bancorp (FINW) - FinWise Bancorp (FINW) 是FinWise Bank的银行控股公司，当前年度盈利预期在过去60天内下调了7.5%[3]